P2Earn Inc. (CSE:PXE)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Apr 28, 2025, 11:53 AM EST
P2Earn Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | - | 0.26 | 0.22 | 0.16 | |
Revenue Growth | - | - | - | 15.71% | 40.95% | - |
Cost of Revenue | - | - | - | 0.26 | 0.14 | 0.18 |
Gross Profit | - | - | - | 0 | 0.08 | -0.02 |
Selling, General & Admin | 0.16 | 0.17 | 0.4 | 2.09 | 1.5 | 2.9 |
Amortization of Goodwill & Intangibles | 0 | 0 | 0.03 | 0.68 | 0.48 | 0.23 |
Operating Expenses | 0.16 | 0.18 | 0.47 | 2.77 | 1.99 | 3.13 |
Operating Income | -0.16 | -0.18 | -0.47 | -2.77 | -1.91 | -3.16 |
Interest Expense | -0 | -0 | -0 | -0.01 | -0.01 | -0.01 |
Currency Exchange Gain (Loss) | - | - | -0.01 | -0 | - | 0.04 |
Other Non Operating Income (Expenses) | - | - | - | 0.47 | 3.8 | 3.69 |
EBT Excluding Unusual Items | -0.17 | -0.18 | -0.48 | -2.31 | 1.88 | 0.57 |
Impairment of Goodwill | - | - | - | -4.83 | - | -2.42 |
Gain (Loss) on Sale of Assets | - | - | 0 | -0.32 | 0 | - |
Asset Writedown | - | - | -0 | -0.02 | - | -1.09 |
Other Unusual Items | - | - | - | -0 | 1.27 | 0.02 |
Pretax Income | -0.17 | -0.18 | -0.48 | -7.49 | 3.15 | -2.92 |
Earnings From Continuing Operations | -0.17 | -0.18 | -0.48 | -7.49 | 3.15 | -2.92 |
Minority Interest in Earnings | - | - | - | - | 0 | 0 |
Net Income | -0.17 | -0.18 | -0.48 | -7.49 | 3.15 | -2.92 |
Net Income to Common | -0.17 | -0.18 | -0.48 | -7.49 | 3.15 | -2.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 94 | 94 | 82 | 64 | 38 | 16 |
Shares Outstanding (Diluted) | 94 | 94 | 82 | 64 | 38 | 16 |
Shares Change | 6.51% | 14.29% | 29.02% | 69.51% | 130.62% | 257.36% |
EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.12 | 0.08 | -0.18 |
EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.12 | 0.08 | -0.18 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0 | -0 | 0.02 | -1.29 | -0.11 | -4.8 |
Free Cash Flow Per Share | - | - | - | -0.02 | -0.00 | -0.29 |
Gross Margin | - | - | - | 0.25% | 34.71% | -14.38% |
Operating Margin | - | - | - | -1080.01% | -861.57% | -2008.22% |
Profit Margin | - | - | - | -2920.91% | 1421.35% | -1859.21% |
Free Cash Flow Margin | - | - | - | -501.86% | -49.75% | -3050.30% |
EBITDA | -0.16 | -0.17 | -0.46 | -2.09 | -1.49 | -2.96 |
D&A For EBITDA | 0 | 0 | 0 | 0.68 | 0.42 | 0.2 |
EBIT | -0.16 | -0.18 | -0.47 | -2.77 | -1.91 | -3.16 |